Retatrutide: What It Is and Why You Can't Get It Yet

Retatrutide is an investigational medicine in late-stage studies as of the publish date. Lilly has said it plans to submit it to the FDA in 2027, so it is not yet available at retail pharmacies. In practical terms, your prescriber cannot write a standard prescription for retatrutide today. The only legitimate path to receiving it is participation in a clinical trial.

Anything being sold online under the name “retatrutide” is unapproved and not legally prescribable outside trials. These products may be mislabeled, contaminated, or not contain what they claim. Also avoid “research-use” or “not for human use” versions marketed to consumers. If you see an ad that promises fast shipping or “no prescription,” assume it is not a legitimate medical supply channel.

If you are interested in retatrutide specifically, the realistic next step is to ask your clinician whether a clinical trial could be a fit. Trials have strict inclusion rules and may require extra visits, lab work, and follow-up. Do not stop or switch your current GLP-1 medicine to try to qualify without medical guidance. If you do find a trial, confirm it is run through a reputable site and that the medication is provided through the study.

While retatrutide is not available yet, there are FDA-approved options that many people use right now, including injections and newer GLP-1 pills. If you are thinking about changing treatment because of side effects, cost, or results, bring those goals to your prescriber. They can help you compare what is approved and actually accessible today. This keeps your plan safer and more predictable than chasing an investigational drug.

Some people using compounded versions of GLP-1 medicines may see marketing that implies access to “the newest” molecules. Retatrutide is not legally prescribable outside trials, so any source claiming otherwise is a serious warning sign. If you are using a compounded product and you’re unsure what you’re receiving, take the label and packaging details to your pharmacist or prescribing clinician. They can help you understand what you have without relying on online claims.

Bring three items: your current medication name and dose, a simple timeline of your results and side effects, and your top priority (for example, appetite control, blood sugar stability, or fewer GI symptoms). Ask your prescriber what milestones would justify staying the course versus considering an approved alternative. If contraception, pregnancy planning, breastfeeding, or hormone therapy is relevant, raise it directly, since GLP-1 medicines are generally not recommended during pregnancy. For any interaction questions with your other medications, use your pharmacist as your first stop.